scispace - formally typeset
Open AccessJournal ArticleDOI

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Behnood Bikdeli, +50 more
- 16 Jun 2020 - 
- Vol. 75, Iss: 23, pp 2950-2973
TLDR
The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
About
This article is published in Journal of the American College of Cardiology.The article was published on 2020-06-16 and is currently open access. It has received 2222 citations till now. The article focuses on the topics: Platelet activation & Antithrombotic.

read more

Citations
More filters
Journal ArticleDOI

Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-Analysis

TL;DR: Use of thrombolytics was associated with lower all-cause mortality, lower risk of recurrent pulmonary embolism, and greater risks of major bleeding in patients 65 years and younger.
Journal ArticleDOI

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management.

TL;DR: Cerebrovascular events are relatively common findings in COVID-19 infection, and they could have a multifactorial etiology, and more accurate and prospective data are needed to better understand the impact of cerebrov vascular events in COIDs.
Journal ArticleDOI

Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?

TL;DR: Renal function did not deteriorate and signs of rejection were not observed in any patient on the second treatment regime, suggesting immunosuppressant treatment based on cyclosporine could be safe and effective for KTRs diagnosed with COVID‐19.
Journal ArticleDOI

Urgent reconsideration of lung edema as a preventable outcome in COVID-19: Inhibition of TRPV4 represents a promising and feasible approach

TL;DR: This work argues for inhibition of the transient receptor potential vanilloid 4 (TRPV4) calcium-permeable ion channel as a strategy to address the alveolo-capillary barrier of the lung and argues for expeditious clinical testing of this inhibitor in COVID-19 patients with respiratory malfunction and at risk for lung edema.
Journal ArticleDOI

COVID-19 Vaccines: Should We Fear ADE?

TL;DR: Safe and effective COVID 19 vaccines must avoid VAH, and this outcome is unlikely because coronavirus diseases in humans lack the clinical, epidemiological, biological or pathological attributes of ADE disease exemplified by the dengue viruses.
References
More filters
Journal ArticleDOI

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI

A pneumonia outbreak associated with a new coronavirus of probable bat origin

TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

TL;DR: The epidemiological and clinical characteristics of novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China, and hospital-associated transmission as the presumed mechanism of infection for affected health professionals and hospitalized patients are described.
Related Papers (5)